INTERREG 2 Seas – CoBra – Development of a new medical robot for diagnosis and treatment of localized cancers
Goal:
Enhance the pratice of Brachytherapy with the development of a new medical robot prototype for diagnosis and treatment of local cancers like Prostate one.
Activities carried out by Eurasanté:
- Communication activities, building a network and organizing events
- Provide socioeconomic studies and a mapping of persons affected by Brachytherapy (patients and health practitioners)
- Technological transfer
Duration: 57 months
Planning: from 01/01/2018 to 30/09/2022
Budget: € 3 801 252
Head of project: University of Lille (FR)
- Centre Oscar Lambret (FR)
- Delft University of Technology (NL)
- University of Portsmouth (R.-U.)
- Eurasanté (FR)
- Demcon Advanced Mechatronics West B.V. (NL)
- SATT-Nord (FR)
- Centre de cancérologie vétérinaire Oncovet (FR)
- Portsmouth Hospitals NHS Trust (R.-U.)
- Demcon Advanced Mechatronics B.V. (NL)
With the support of the European Regional Development Fund
